These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7263964)

  • 21. Fetal hydantoin syndrome: a case report.
    Nanda A; Kaur S; Bhakoo ON; Kapoor MM; Kanwar AJ
    Pediatr Dermatol; 1989 Jun; 6(2):130-3. PubMed ID: 2501774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The fetal hydantoin syndrome (author's transl)].
    Frontera-Izquierdo P; Cabezuelo-Huerta G; Mulas F
    An Esp Pediatr; 1981 Jun; 14(6):411-5. PubMed ID: 7294529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe cardiac and ophthalmologic malformations in an infant exposed to diphenylhydantoin in utero.
    Bartoshesky LE; Bhan I; Nagpaul K; Pashayan H
    Pediatrics; 1982 Feb; 69(2):202-3. PubMed ID: 7058095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nail hyperpigmentation secondary to therapy with doxorubicin.
    Giacobetti R; Esterly NB; Morgan ER
    Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minor anomalies in offspring of epileptic mothers.
    Gaily E; Granström ML; Hiilesmaa V; Bardy A
    J Pediatr; 1988 Apr; 112(4):520-9. PubMed ID: 3351676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal prediction of risk of the fetal hydantoin syndrome.
    Buehler BA; Bick D; Delimont D
    N Engl J Med; 1993 Nov; 329(22):1660-1. PubMed ID: 8232451
    [No Abstract]   [Full Text] [Related]  

  • 27. Painful discoloration of the fingernails in a 15-year-old boy.
    Coffin SE; Puck J
    Pediatr Infect Dis J; 1993 Aug; 12(8):702-3; 706. PubMed ID: 8414789
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroblastoma and fetal exposure to phenytoin in a child without dysmorphic features.
    al-Shammri S; Guberman A; Hsu E
    Can J Neurol Sci; 1992 May; 19(2):243-5. PubMed ID: 1623454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal hydantoin syndrome, neuroblastoma, and hemorrhagic disease in a neonate.
    Allen RW; Ogden B; Bentley FL; Jung AL
    JAMA; 1980 Sep; 244(13):1464-5. PubMed ID: 7420637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoplasia of nails and phalanges: a teratogenic manifestation of diphenyl hydantoin sodium.
    Prakash P; Saxena S; Raturi BM
    Indian Pediatr; 1978 Oct; 15(10):866-7. PubMed ID: 730315
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital Absence of Nails and Digital-Type Thumb due to Prenatal Phenytoin Exposure.
    Karbhari Pawar M; Zawar V
    Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):778-780. PubMed ID: 31122647
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero.
    Seip M
    Acta Paediatr Scand; 1976 Sep; 65(5):617-21. PubMed ID: 822687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diphenylhydantoin teratogenicity: ocular manifestations and related deformities.
    Wilson RS; Smead W; Char F
    J Pediatr Ophthalmol Strabismus; 1978; 15(3):137-40. PubMed ID: 105119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal hydantoin syndrome with rheumatic valvular heart disease.
    Godbole KG; Gambhir PS; Deshpande AS; Kurlekar SU; Phadke MA
    Indian J Pediatr; 1999; 66(2):290-3. PubMed ID: 10798072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenytoin teratogenicity in man.
    Loughnan PM; Gold H; Vance JC
    Lancet; 1973 Jan; 1(7794):70-2. PubMed ID: 4118650
    [No Abstract]   [Full Text] [Related]  

  • 36. Melanotic neuroectodermal tumor of infancy and fetal hydantoin syndrome.
    Jimenez JF; Seibert RW; Char F; Brown RE; Seibert JJ
    Am J Pediatr Hematol Oncol; 1981; 3(1):9-15. PubMed ID: 6263127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding.
    Vomvouras S; Pakula AS; Shaw JM
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):1016-7. PubMed ID: 1869665
    [No Abstract]   [Full Text] [Related]  

  • 38. Universal cutaneous depigmentation following phenytoin-induced toxic epidermal necrolysis.
    Smith DA; Burgdorf WH
    J Am Acad Dermatol; 1984 Jan; 10(1):106-9. PubMed ID: 6693586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.
    Hanson JW; Myrianthopoulos NC; Harvey MA; Smith DW
    J Pediatr; 1976 Oct; 89(4):662-8. PubMed ID: 957016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide-induced nail pigmentation.
    Srikant M; Van Veen J; Raithatha A; Reilly JT
    Br J Haematol; 2002 Apr; 117(1):2. PubMed ID: 11918527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.